Related references
Note: Only part of the references are listed.Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas
Mohammad A. Al Efishat et al.
ANNALS OF SURGERY (2018)
Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms
Abdurrahman Kadayifci et al.
DIGESTIVE ENDOSCOPY (2017)
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
Jun Yu et al.
GUT (2017)
Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia
Michele T. Yip-Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2017)
MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm
Lei Wang et al.
ONCOTARGET (2017)
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Sujuan Yang et al.
CANCER BIOLOGY & THERAPY (2017)
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2017)
MicroRNAs for Detection of Pancreatic Neoplasia Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts
Elena Vila-Navarro et al.
ANNALS OF SURGERY (2017)
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract Recommendations of Verona Consensus Meeting
Volkan Adsay et al.
ANNALS OF SURGERY (2016)
Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas
Pamela L. Beatty et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
Andreas W. Berger et al.
GASTROENTEROLOGY (2016)
Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts
Martin Jones et al.
GASTROINTESTINAL ENDOSCOPY (2016)
GLI2 PROTEIN EXPRESSION LEVEL IS A FEASIBLE MARKER OF LIGAND-DEPENDENT HEDGEHOG ACTIVATION IN PANCREATIC NEOPLASMS
Yoshiaki Sugiyama et al.
POLISH JOURNAL OF PATHOLOGY (2016)
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas
Jessica Sinha et al.
PLoS One (2016)
Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas
Barbara Bournet et al.
ENDOSCOPY INTERNATIONAL OPEN (2016)
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions
Jin Wang et al.
CANCER LETTERS (2015)
Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
Jennifer Permuth-Wey et al.
CANCER PREVENTION RESEARCH (2015)
KRAS and Guanine Nucleotide-Binding Protein Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound
James R. Eshleman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Simeon Springer et al.
GASTROENTEROLOGY (2015)
The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms
Kota Arima et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas
Jae Ri Kim et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma
Marcus C. Tan et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Cyst Fluid Biomarkers for Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Critical Review from the International Expert Meeting on Pancreatic Branch-Duct-Intraductal Papillary Mucinous Neoplasms
Ajay V. Maker et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas With Concomitant Pancreatic Ductal Adenocarcinoma
Noboru Ideno et al.
PANCREAS (2015)
Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas
Yuko Kuboki et al.
PANCREAS (2015)
Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas
Yutaka Akimoto et al.
PANCREATOLOGY (2015)
GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas
Waki Hosoda et al.
VIRCHOWS ARCHIV (2015)
Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas
Mathieu Daude et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts
Mohammad A. Al-Haddad et al.
ENDOSCOPY (2015)
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
Makoto Abue et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas
Hitomi Sakamoto et al.
MODERN PATHOLOGY (2015)
A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas
Jennifer Permuth-Wey et al.
PLOS ONE (2015)
Salivary MicroRNA in Pancreatic Cancer Patients
Marine Humeau et al.
PLOS ONE (2015)
Epithelial-to-Mesenchymal Transition (EMT) in Intraductal Papillary Mucinous Neoplasm (IPMN) is Associated with High Tumor Grade and Adverse Outcomes
Guy Lahat et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer
Haoxuan Zheng et al.
CARCINOGENESIS (2014)
Preoperative GNAS and KRAS Testing in the Diagnosis of Pancreatic Mucinous Cysts
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2014)
EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27Kip1 Downregulation
Hideyuki Kuroki et al.
PLOS ONE (2014)
A systematic review of the Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity and its Portsmouth modification as predictors of post-operative morbidity and mortality in patients undergoing pancreatic surgery
Haolu Wang et al.
AMERICAN JOURNAL OF SURGERY (2013)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
Neeley Remmers et al.
CLINICAL CANCER RESEARCH (2013)
Mutant TP53 in Duodenal Samples of Pancreatic Juice From Patients With Pancreatic Cancer or High-Grade Dysplasia
Mitsuro Kanda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-Analysis
Neeraj Anand et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Cyst carcinoembryonic antigen in differentiating pancreatic cysts: A meta-analysis
Saowanee Ngamruengphong et al.
DIGESTIVE AND LIVER DISEASE (2013)
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts
Mitsuro Kanda et al.
GUT (2013)
Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts
Marina N. Nikiforova et al.
MODERN PATHOLOGY (2013)
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Xiaomo Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas
Nir Lubezky et al.
SURGERY (2013)
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer
Suguru Yamada et al.
SURGERY (2013)
Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells
Jason A. Castellanos et al.
ONCOTARGETS AND THERAPY (2013)
Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Seung-Mo Hong et al.
CLINICAL CANCER RESEARCH (2012)
MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Jun Yu et al.
CLINICAL CANCER RESEARCH (2012)
TP53 Genomic Status Regulates Sensitivity of Gastric Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep)
Lai Ling Cheng et al.
CLINICAL CANCER RESEARCH (2012)
miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts
Hanno Matthaei et al.
CLINICAL CANCER RESEARCH (2012)
Carcino Embryonic Antigen and long-term follow-up of mucinous pancreatic cysts including intraductal papillary mucinous neoplasm
Mohamed O. Othman et al.
DIGESTIVE AND LIVER DISEASE (2012)
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas
Marco Dal Molin et al.
HUMAN PATHOLOGY (2012)
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
Tetsuhiro Chiba et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
Junko Kikuchi et al.
LUNG CANCER (2012)
Genetic Markers of Malignant Transformation in Intraductal Papillary Mucinous Neoplasm of the Pancreas A Meta-Analysis
Sahar Nissim et al.
PANCREAS (2012)
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Masao Tanaka et al.
PANCREATOLOGY (2012)
Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers
Ada Piepoli et al.
PLOS ONE (2012)
Mucin Expression Pattern in Pancreatic Diseases: Findings From EUS-Guided Fine-Needle Aspiration Biopsies
Silvia Carrara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Ajay V. Maker et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas
S. Fritz et al.
BRITISH JOURNAL OF SURGERY (2011)
Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Ajay V. Maker et al.
CLINICAL CANCER RESEARCH (2011)
Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma
Ji Kon Ryu et al.
PANCREATOLOGY (2011)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Jian Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
S. Bafna et al.
ONCOGENE (2010)
Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study
Asif Khalid et al.
GASTROINTESTINAL ENDOSCOPY (2009)
Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas
Jin-Young Jang et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2009)
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Julian Puppe et al.
BREAST CANCER RESEARCH (2009)
Prevalence of unsuspected pancreatic cysts on MDCT
Thomas A. Laffan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Cytology from Pancreatic Cysts Has Marginal Utility in Surgical Decision-Making
Ajay V. Maker et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues
Anna E. y Szafranska et al.
CLINICAL CHEMISTRY (2008)
PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas
Frank Schoenleben et al.
LANGENBECKS ARCHIVES OF SURGERY (2008)
Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas
Frank Scho Nleben et al.
PANCREAS (2008)
Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures
Eiji Miyoshi et al.
PROTEOMICS (2008)
Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior
Suguru Yonezawa et al.
PROTEOMICS (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
PGE2 in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia
C. Max Schmidt et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas
Yasushi Hashimoto et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Pancreatic intraductal papillary-mucinous neoplasms:: a new and evolving entity
Snezana Andrejevic-Blant et al.
VIRCHOWS ARCHIV (2007)
Immunohistochemical expression of sonic hedgehog in intraductal papillary mucinous tumor of the pancreas
Kee-Taek Jang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas
Yoshihiro Miyasaka et al.
CLINICAL CANCER RESEARCH (2007)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Mucin expression profile in pancreatic cancer and the precursor lesions
Kohji Nagata et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2007)
Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia
Keiko Abe et al.
PANCREAS (2007)
Endoscopic ultrasound-guided fine needle aspiration biopsy: Equipment and technique
Peter Vilmann et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice
K. Ohuchida et al.
JOURNAL OF PATHOLOGY (2006)
Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?
Kyung W. Noh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas
M Kitago et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy
N Moniaux et al.
BRITISH JOURNAL OF CANCER (2004)
Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study
WR Brugge et al.
GASTROENTEROLOGY (2004)
Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer
Y Hamanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions
B Terris et al.
JOURNAL OF PATHOLOGY (2002)
Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma
AV Biankin et al.
GUT (2002)
New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy
A Nakamura et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
